Tourmaline Bio Rings the Closing Bell
About This Event
Tourmaline Bio, Inc. (Tourmaline) (Nasdaq: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Sandeep Kulkarni, Chief Executive Officer, rings the Closing Bell.